Acquisition

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

The deal combines Remsoft's analytics with INFLOR's forest management system, creating a powerful end-to-end platform for the global forestry value chain.

With rapid trial enrollment for a novel drug, Pulmovant offers a potential lifeline for patients with PH-ILD, a condition with few to no options.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

As Alberta prepares its regulated iGaming market, BetRivers launches pre-registration and unveils an exclusive Olympic partnership with national broadcaster CBC.

The Nutella maker posts strong growth, but its acquisitions of Kellogg's cereals and Power Crunch signal a bold new strategy beyond confectionery.

A surprise move by a joint venture partner to exercise pre-emption rights has thrown Maurel & Prom’s major Angolan oil field acquisition into uncertainty.

LG Energy Solution acquires Stellantis's stake in Canada's NextStar battery plant, signaling a major strategic shift towards the energy storage market.

A $41.25M deal for a new cottage-style community in Monroe, NC, highlights a growing housing trend and an investor's bet on 'affordable' suburban living.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

Stablecoin giant Tether's $150M investment in Gold.com signals a new era, merging physical gold with blockchain to redefine asset ownership.

Following a massive acquisition, VSE Corp. prepares to outline its future growth and market strategy at two major February investor conferences.

Cousins Properties acquires a premier Charlotte tower for $317.5M, doubling down on the 'flight to quality' trend in a complex office market.

As Vinci Compass preps its full-year 2025 results, investors watch for signs of strength in Latin America's burgeoning alternative asset market.

AI-powered reAlpha has launched a new platform to unify the fragmented homebuying journey. Can its integrated approach truly simplify the process for buyers?

With 50,000 businesses set to sell, a new movement aims to tackle a succession crisis by empowering an untapped resource: women entrepreneurs.

As Churchill Capital XI's shares and warrants begin separate trading, what does this mean for investors and the hunt for Michael Klein's next big deal?

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.